New sites available now on Bearcats Landing

Visit the new sites launched on Bearcats Landing at my.uc.edu (UC login required)

UC Faculty and staff now have even more content to visit in Bearcats Landing, UC's intranet.

Visit the New Sites Launched (Spring Semester 2022) Bearcats Landing news article (UC Login required) to learn more about the following areas' new sites:


What is Bearcats Landing?

Bearcat mascot holding a sign that reads "My Bearcats Landing"; banner announcing "New sites launched"

Bearcats Landing is a desktop and mobile-friendly platform that develops and strengthens university-wide partnerships to support our future-facing evolution. It provides UC faculty and staff with the role-based tools and resources they need to increase communication and engagement.

Bearcats Landing is UC’s employee home base to read news and announcements, discover events and workshops, and find information essential to keeping the university running smoothly. It works to strengthen our professional community and capitalizes on our workplace diversity to empower individuals to be leaders in workplace. Even as our community grows more remote, we are still connected through the information-sharing and collaboration that takes place on Bearcats Landing.


Related Stories

1

Recent advances may speed time to endometriosis diagnosis

March 16, 2026

The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.

3

Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy

March 16, 2026

Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.